SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-130956
Filing Date
2023-05-02
Accepted
2023-05-01 20:55:01
Documents
13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d462998ddefa14a.htm DEFA14A 17377
2 EX-1 d462998dex1.htm EX-1 30266
3 EX-2 d462998dex2.htm EX-2 969
4 STOCKHOLDER LETTER d462998ddefa14a1.pdf DEFA14A 584853
5 GRAPHIC g462998page005.jpg GRAPHIC 233884
6 GRAPHIC g462998page006.jpg GRAPHIC 273912
7 GRAPHIC g462998page007.jpg GRAPHIC 225368
8 GRAPHIC g462998page008.jpg GRAPHIC 274587
9 GRAPHIC g462998page009.jpg GRAPHIC 308920
10 GRAPHIC g462998page010.jpg GRAPHIC 240949
11 GRAPHIC g462998page011.jpg GRAPHIC 265398
12 GRAPHIC g462998page012.jpg GRAPHIC 245666
13 GRAPHIC g462998page015.jpg GRAPHIC 100748
  Complete submission text file 0001193125-23-130956.txt   3844178
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30235 | Film No.: 23876212
SIC: 2836 Biological Products, (No Diagnostic Substances)